NEW YORK, July 15 (GenomeWeb News) - BioTrove announced Thursday that it has acquired an exclusive license from Stanford University for patent applications covering the use of a through-hole structured microarray to perform PCR.
BioTrove also said it has received a patent on a novel method using the company's proprietary OpenArray platform for high-density cell assay and culture. BioTrove is commercializing the platform, a nanofluidic system for massively parallel analysis using Thru-Hole technology, for use by life science researchers.
The patent covers an innovative application of the OpenArray technology that allows for the maintenance and growth of cells in a microfluidic environment, with potential application in cell-based assays.
BioTrove's through-hole intellectual property portfolio now includes eight patents issued or allowed and numerous patents pending, according to the Woburn, Mass.-based firm.